Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of ASF 1057 Cream 0.5% in the Treatment of Seborrhoeic Dermatitis: A Phase III Randomised, Double-Blind, Vehicle and Placebo Controlled, Parallel Groups, Multi-Centre Trial.
Conditions
Interventions
ASF1057
ASF1057
Start Date
December 1, 2007
Primary Completion Date
May 1, 2008
Completion Date
June 1, 2008
Last Updated
June 3, 2008
NCT05319444
NCT04445987
NCT01703793
Lead Sponsor
Astion Pharma A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions